Rotavirus Vaccines
Investigators at Erasmus University, Institute for Medical Technology Assessment have published new data on rotavirus vaccines
Published in Vaccine Weekly, April 2nd, 2008
Data detailed in 'The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands' have been presented. "The objective of this study was to estimate the cost-utility of mass vaccination of 0-4-year-old children with Rotarix in the Netherlands. We used a Markov process with Dutch data on incidence, resource use and costs (GP, hospitalisation, productivity loss and household costs) to compare vaccination to conventional treatment from a societal perspective," scientists writing in the journal Vaccine report.
"Utility loss due to rotavirus-induced diarrhoea was measured using EQ5D, with GPs and paediatricians serving as proxies to fill out the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-04-02)
More Articles from Vaccine Weekly
- Dengue Fever
Studies from National Heart, Lung, & Blood Institute provide new data on dengue fever - DNA Vaccines
Researchers at University of Pennsylvania, Medical Department target DNA vaccines - Genetics & Genomics
Findings from University of Oxford provide new insights into genetics & genomics - Influenza
New influenza research from Niigata University described - Influenza
Research reports on influenza from Z.Y. Chen and colleagues provide new insights - Influenza
Study data from D.A. Kaminski and colleagues update understanding of influenza - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
